FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
1.125
-0.115 (-9.27%)
At close: Feb 21, 2025, 4:00 PM
1.130
+0.005 (0.44%)
After-hours: Feb 21, 2025, 6:50 PM EST
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $39.47 million as of February 21, 2025. Its market cap has decreased by -88.24% in one year.
Market Cap
39.47M
Enterprise Value
33.21M
1-Year Change
-88.24%
Ranking
Category
Stock Price
$1.13
Market Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $39.47M, a decrease of -95.83%. That is a compound annual growth rate of -95.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 39.47M | -43.75% |
| Dec 31, 2024 | 70.17M | -92.58% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.21B |
| UnitedHealth Group | 462.37B |
| Johnson & Johnson | 384.45B |
| Novo Nordisk | 370.84B |
| AbbVie | 354.62B |
| Abbott Laboratories | 230.98B |
| AstraZeneca | 227.07B |
| Merck & Co. | 221.80B |